FED Decision

Wall Street Warrior Presents ➡ ➡ ➡ Yesterday the FED announced another interest rate hike. And it’s unlikely they’ll change pace as inflation persists. “It’s very premature in my view to be thinking about or talking about pausing our rate hike. We have a ways to go.” Jerome Powell Here are the details. Market’s didn’t take the news very well. Here’s a chart of the SPDR Dow Jones Industrial Average ETF (NYSE: DIA) … Sponsored 97% Accuracy For The Last 8 Years… Really? If that sounds too good to be true… trust me, I get it. But one trader has done just that, holding one of the top track records on Wall Street in recent years. Regardless of bull or bear markets his 9/10 win rate has held strong (with no signs of slowing down). Now he wants YOU to have the same opportunity to rack up incredible gains, no matter what the market does next. Still not convinced? Click HERE to see it with your own eyes. Privacy Policy/Disclosures Trading’s been slow as a result. And it will likely continue at that pace until the mid-term elections next week. A lot of people aren’t content with the U.S. government right now. Inflation is still high. Interest rates keep going up. Only40% of people polled approve of Biden’s efforts in the White House. The mid-term elections offer citizens a chance to influence the country’s direction. And it’s likely the catalyst will result in volatile price movements. But there’s still a play to make. Even in this market. So, while we wait for Tuesday’s results … turn you attention to stocks like Provetion Bio Inc. (NASDAQ: PRVB) The chart says it all. In early October the price spiked through resistance and put in a new top at $8. Today, it announced news with the FDA and rocketed through $8 on higher volume. Read the news here. Take a look at this price action … This isn’t the market to take chances. Stick to your patterns and trade the best setups. Next week is gonna get crazy! Guardian Financial Publishing 3571 Far West Blvd Austin, TX 78731 test This email was sent to {EMAIL}. Don't want to receive these emails anymore?Unsubscribe Privacy Policy | Terms | Risk Disclosure